Profile
The Department provides comprehensive diagnostics and therapies for urological diseases, including major surgeries on the bladder, prostate, and kidneys (such as cystectomy, bladder replacement, prostatectomy, and (partial) nephrectomy). It also offers minimally invasive prostate therapies (TUR-P, HIFU, thermotherapy, laser-enucleation), endoscopic, laparoscopic, and robotic surgeries on kidneys and adrenal glands, urethral surgery, and complex reconstructive procedures.
External Partners
Prof. Marianna Rapsomaniki, UNIL/CHUV Lausanne; Prof. Alvaro Aytes Institut d’Investigació Biomèdica de Bellvitge, Program Against Cancer Therapeutic Resistance / Prostate Cancer Lab, Barcelona, Spain; Prof. Theodore Alexandrov EMBL-Heidelberg, Structural and Computational Biology / Spatial Metabolomics Lab, Heidelberg, Germany; Prof. Rosalyn Adam, Urological Diseases Research Center, Boston Children’s Hospital, Boston, USA; Prof. Todd Purves, Duke University, Durham USA; Swiss Institute for Bioinformatics, TKI Bern, ETH Zürich, Balgrist University Hospital, ZHAW and EPFL; Prof. Ilaria Lucca, head of the department of Urology, CHUV, Lausanne, Prof. Joseph Liao Stanford University, Prof. Phil A. Beachy Stanford University
Grants
3RCC (OC-2019-003); SNSF Sinergia (202297); SNSF SPARK (228930); SNSF SPARK (212298); Innosuisse (101.951 IP-LS, 104.320 IP-LS); Wilhelm Sander Foundation (2022.136.1); Swiss Cancer League (KFS-5510-02-2022-R); EUREKA Eurostar (E!5995; E!6012) ISREC-TANDEM (CCP 10-3224-9); Novartis 23B099; SF Board of the Faculty of Medicine; Swiss National Science SISF; SNSF R’Equip (229688); International Foundation for Research in Paraplegia (P195); Leenaards Foundation 2023
